drugset / Trial / NCT02587260

Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)

NCT02587260

Phase 4 Completed 54 enrolled Erasmus Medical Center Covance · collab
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this randomized, cross-over study, is to ascertain if ticagrelor, but not prasugrel or clopidogrel, is associated to an improved endothelial function as assessed with peripheral arterial tonometry and markers of endothelial function measurement in post-ACS patients.

Timeline

Start
2015-12-17
Primary completion
2017-02-10
Completion
2017-02-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg Oral
Comparator Prasugrel Small molecule 5 mg Oral
Comparator Prasugrel Small molecule 10 mg Oral
Comparator Ticagrelor Small molecule 90 mg Oral